Abstract
Estrogen replacement therapy (ERT) prevents fractures and relieves vasomotor symptoms, but it increases the risk of endometrial cancer. Previous studies and national prescribing patterns show that physicians are conservative in their approach to this therapy. The authors interviewed physicians and perimenopausal women to assess their utilities for the various health outcomes of estrogen replacement therapy. On all outcomes, physicians rated illness episodes followed by recovery as being closer to perfect health than did perimenopausal women. Physicians, in judging which outcomes were most important to women, estimated relief of symptoms above fracture prevention, whereas women rated fracture prevention above symptom relief. These results emphasize the need to assess patients’ utilities directly, particularly when utilities for the outcome of a particular therapy may influence the choice of a therapeutic regimen.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Osteoporosis. National Institutes of Health Consensus Conference Statements. JAMA volume 5, number 3
Bush T, Cowan L, Barrett-Connor E et al. Estrogen use and all-cause mortality. JAMA 1983;249:903–6
Kennedy DL, Baum C, Forbes MB. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol 1985;65:441–6
Elstein AS, Holzman GB, Ravitch MM, et al. Comparison of physicians’ decisions regarding estrogen replacement therapy for menopausal women and decisions derived from a decision analytic model. Am J Med 1985;80:246–8
Cancer Statistics, 1986. CA 1986;36:9–25
Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985;7:178–207
Weinstein M, Schiff T. Cost-effectiveness of hormone replacement therapy in the menopause. Obstet Gynecol Survey 1983;38:445–55
Holzman G, Ravitch M, Metheny W, Rothert M, Holmes M, Hoppe R. Physicians’ judgments about estrogen replacement therapy for menopausal women. Obstet Gynecol 1984;63:303–11
Raffia H. Decision analysis: introductory lectures on choices under uncertainty. Reading, MA: Addison-Wesley, 1968
Edwards W. How to use multi-attribute utility measurement for social decisions. IEEE Transactions on Systems, Man and Cybernetics 1977;(7):326–40
Rovner DR, Holmes MM, Rothert ML, Elstein AS. States worse than death: premenopausal women and physicians preferences for death and disability. Med Decis Making 1985;4:541
Leighton-Reid J, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes comparison of assessment methods. Med Decis Making 1984;4:315–29
Eraker SA, Sox HC. Assessment of patient’s preferences for therapeutic outcomes. Med Decis Making 1981;1:29–39
Weinstein MC, Feinberg HV, Elstein AS, et al. Clinical decision analysis. Philadelphia: W. B. Saunders. 1980
McNeil BJ, Pauker SG, Sox HC, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med 1982;306:1259–63
Author information
Authors and Affiliations
Additional information
Supported in part by a grant from the National Fund for Medical Education, #47/81.
Rights and permissions
About this article
Cite this article
Holmes, M.M., Rovner, D.R., Rothert, M.L. et al. Women’s and physicians’ utilities for health outcomes in estrogen replacement therapy. J Gen Intern Med 2, 178–182 (1987). https://doi.org/10.1007/BF02596148
Issue Date:
DOI: https://doi.org/10.1007/BF02596148